About this trial
This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Identifies as African American or Black
15-26 years of age
Lives or spends most of their time in Orleans Parish
Had vaginal sex at least once
Disqualifiers
Unwilling or unable to provide informed consent
Unable to speak or understand English
Previously enrolled in the study
Trial design
Single group
Treatments tested in this trial
Chlamydia, gonorrhea, syphilis, and HIV screening
Other interventionIndividuals aged 15-26 years old will be tested for chlamydia, gonorrhea, HIV, and syphilis at community based venues. Individuals who test positive for chlamydia and gonorrhea and their sexual partners will be offered expedited treatment at participating pharmacies. Individuals who test positive will be asked to be rescreened for Ct/GC at 3 months post treatment.
Treatment groups
Trial outcomes
Primary outcomes
Rate of chlamydia in women
Primary outcome
Secondary outcomes
Index participant medication pickup rate
Percentage of index participants who obtain their prescribed medication from a partnering pharmacy among all index participants who report intending to pick up the medication. Medication receipt will be determined from pharmacy billing records. Rates will be calculated monthly.
Partner medication pickup rate
Percentage of partners who obtain their prescribed medication from a partnering pharmacy among all partners reported as intending to pick up the medication. Medication receipt will be determined from pharmacy billing records. Rates will be calculated monthly.
Self reported treatment of index participants and partners
Number and percentage of index participants who report that they and all applicable partner(s) received treatment. The denominator will include index participants who provide follow-up information about their own and their partner(s)' treatment status.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Tulane University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator